Pearl C. Ozuruigbo

FDA investigator

Appears on 6 documents from 2024 to 2026, mostly at sites in California. Most often cites production record review (21 CFR 211.192).

6
Documents on file
5.2
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 31 observations

Activity by year

2024: 3, 2025: 1, 2026: 2

Where

California 4 · Mississippi 1

Is Pearl C. Ozuruigbo coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Cardinal Health 414, LLCMar 18, 2026 · Jackson, Mississippi
483 K.C. Pharmaceuticals, Inc.Feb 13, 2026 · Pomona, California
483 Ritsa Pharma Private LimitedSep 5, 2025
483 CTK OTC Laboratories LLCDec 31, 2024 · CORONA, California
483 Prisha Cosmetics, Inc.Nov 22, 2024 · Chatsworth, California
483 McGuff Pharmaceuticals, Inc.Jan 26, 2024 · Santa Ana, California

About this profile

What does Pearl C. Ozuruigbo inspect?

Pearl C. Ozuruigbo appears on 6 documents on file covering 6 sites, mostly in California.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Pearl C. Ozuruigbo is dated Mar 18, 2026.